共 11 条
[1]
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomized study. Diabetes Atherosclerosis Intervention Study Investigators. The Lancet . 2001
[2]
Need for large scale randomized evidence about lowering LDL cholesterol in people with diabetes millitus:MRC/BHF heart protection study and other major trials. Armitage J,Collins R. Heart . 2000
[3]
Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Pyorala K,Pederson TR,Kjekshus J,et al. Diabetes Care . 1997
[4]
Cardiovascular events and their reduction with pravastatin in diabetic and glucose intolerant myocardial infarction survivors with average cholesterol levels. Goldberg RB,Mellies MJ,Sacks FM,et al. Circulation . 1998
[5]
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart dis-ease and a broad range of initial cholesterol levels. The Long-TermIntervention with Pravastatinin Ischaemic Dis-ease(LIPID)Study Group. The New England Journal of Medicine . 1998
[6]
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol.Veterans Affairs Highdensity Lipoprotein Cholesterol Intervention Trial Study Group. Rubins HB,Robins SJ,Collins D,et al. The New England Journal of Medicine . 1999
[7]
Design of the Collaborative Atorvastatin Diabetes Study ( CARDS ) in patients with type 2 diabetes. Colhoun HM,Thomason MJ,Mackness MI,et al. Diabetic Medicine . 2002
[8]
Diabetes intervention study: multi-intervention trial in newly diagnosed NIDDM. Hanefeld M,Fischer S,Schmechel H,et al. Diabetes Care . 1991
[9]
Cardiovascular outcomes in type 2 diabetes.A double-blind place-controlled study of bezafibrate: the St. Mary Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention ( SENDCAP) Study. Elkeles RS,Diamond JR,Poulter C,et al. Diabetes Care . 1998
[10]
Preventionofcoronaryheartdiseasewith pravastatininmenwithhypercholesterolemia. ShepherdJ,CobbeSM,FordI,etal. WestofScotlandCoronaryPreventionStudyGroup.NEnglJMed . 1995